The association between aspartate aminotransferase (AST) to platelets (PLT) ratio (APRI) and the development of intrahepatic cholestasis in pregnancy and other related complications.

APRI ICP Intrahepatic cholestasis of pregnancy

Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
15 Feb 2024
Historique:
received: 08 12 2023
accepted: 07 01 2024
medline: 15 2 2024
pubmed: 15 2 2024
entrez: 14 2 2024
Statut: aheadofprint

Résumé

To assess the association between aspartate aminotransferase (AST) to platelet count ratio index (APRI score), during the first and third trimesters of pregnancy and the development of intrahepatic cholestasis in pregnancy (ICP). Case-control study was conducted. The study included patients diagnosed with ICP by elevated bile acids (n = 118) and a control group of women with symptoms such as elevated liver enzymes or pruritus with normal level of bile acids (n = 127) who attended a large tertiary teaching medical center between the years 2014 and 2021. The groups were compared in terms of obstetrical characteristics, perinatal outcomes, first- and third-trimester laboratory tests, and APRI scores during the first and third trimester. A receiver operating characteristic (ROC) analysis was performed to determine the APRI score cutoff value that could predict ICP. The third-trimester APRI scores of patients with ICP were significantly higher than those of the control group (P < 0.001). The ROC analysis revealed that the cutoff value for the APRI score was 0.42 with 65.3% sensitivity and 73.2% specificity. Our results suggest that the third-trimester APRI score is positively associated with ICP.

Identifiants

pubmed: 38355761
doi: 10.1007/s00404-024-07383-8
pii: 10.1007/s00404-024-07383-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Manzotti C, Casazza G, Stimac T, Nikolova D, Gluud C (2019) Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy. Cochrane Database Syst Rev 7:CD012546
Geenes V, Williamson C (2009) Intrahepatic cholestasis of pregnancy. World J Gastroenterol 15(17):2049–2066
doi: 10.3748/wjg.15.2049 pubmed: 19418576 pmcid: 2678574
Floreani A, Gervasi MT (2016) New insights on intrahepatic cholestasis of pregnancy. Clin Liver Dis [Internet] 20(1):177–189. Available from: https://doi.org/10.1016/j.cld.2015.08.010
Kremer AE, Oude Elferink RPJ, Beuers U (2011) Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol 35(2):89–97
doi: 10.1016/j.clinre.2010.10.007 pubmed: 21809485
Tribe RM, Dann AT, Kenyon AP, Seed P, Shennan AH, Mallet A (2010) Longitudinal profiles of 15 serum bile acids in patients with intrahepatic cholestasis of pregnancy. Am J Gastroenterol [Internet] 105(3):585–595. Available from: https://doi.org/10.1038/ajg.2009.633
Mannes GA, Stellaard F, Paumgartner G (1987) Diagnostic sensitivity of fasting and postprandial serum bile acids determined by different methods. Clin Chim Acta 162(2):147–154
doi: 10.1016/0009-8981(87)90446-3 pubmed: 3829420
Mitchell AL, Ovadia C, Syngelaki A, Souretis K, Martineau M, Girling J et al (2021) Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case–control and cohort study. BJOG An Int J Obstet Gynaecol 128(10):1635–1644
doi: 10.1111/1471-0528.16669
Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Illio C, Chambers J et al (2019) Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 393(10174):899–909
doi: 10.1016/S0140-6736(18)31877-4 pubmed: 30773280 pmcid: 6396441
Levanony O, Sheiner E, Kluwgant D, Pariente G (2023) Maternal term pruritus and long-term neuropsychiatric hospitalizations of the offspring. Arch Gynecol Obstet 308(3):857–862
doi: 10.1007/s00404-022-06742-7 pubmed: 36040527
Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS et al (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38(2):518–526
doi: 10.1053/jhep.2003.50346 pubmed: 12883497
Singal AG, Thomassen LV, Gretch DR, Shuhart MC (2011) Use of the AST to platelet ratio index in HCV/HIV co-infected patients. Aliment Pharmacol Ther 33(5):566–577
doi: 10.1111/j.1365-2036.2010.04560.x pubmed: 21205257 pmcid: 3552516
Tolunay HE, Kahraman NÇ, Varlı EN, Ergani SY, Obut M, Çelen Ş et al (2021) First-trimester aspartate aminotransferase to platelet ratio index in predicting intrahepatic cholestasis in pregnancy and its relationship with bile acids: a pilot study. Eur J Obstet Gynecol Reprod Biol 256:114–117
doi: 10.1016/j.ejogrb.2020.11.014 pubmed: 33202320
Kirbas A, Biberoglu E, Daglar K, Iskender C, Erkaya S, Dede H et al (2014) Neutrophil-to-lymphocyte ratio as a diagnostic marker of intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol 180(1):12–15
doi: 10.1016/j.ejogrb.2014.05.042 pubmed: 24997423
Tolunay HE, Kahraman NC, Varli EN, Reis YA, Celen S, Turhan A (2021) Can first-trimester AST to platelet ratio index scores predict HELLP syndrome? 31(02):188–192
Cui D, Zhong Y, Zhang L, Du H (2017) Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: A meta-analysis. J Obstet Gynaecol Res 43(9):1411–1420
doi: 10.1111/jog.13399 pubmed: 28691322
Garcia-Flores J, Cañamares M, Cruceyra M, Garicano A, Espada M, Lopez A, Tamarit I (2015) Clinical value of maternal bile acid quantification in intrahepatic cholestasis of pregnancy as an adverse perinatal outcome predictor. Gynecol Obstet Invest 79:222–228
doi: 10.1159/000370003 pubmed: 25720981
Bicocca MJ, Sperling JD, Chauhan SP (2018) Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol [Internet] 231:180–187. Available from: https://doi.org/10.1016/j.ejogrb.2018.10.041
Pekin O (2017) Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers ? Enflamatuvar belirteçleri kullanarak gebelik kolestazının 4:160–165

Auteurs

Razan Saadi (R)

Department of Obstetrics and Gynecology, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. razans@post.bgu.ac.il.

Alla Saban (A)

Department of Obstetrics and Gynecology, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Adi Y Weintraub (AY)

Department of Obstetrics and Gynecology, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

David Yardeni (D)

Department of Gastroenterology and Liver Diseases, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Tamar Eshkoli (T)

Department of Obstetrics and Gynecology, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Classifications MeSH